Asaduzzaman Muhammad, Constantinou Stephanie, Min Haoxiang, Gallon John, Lin Meng-Lay, Singh Poonam, Raguz Selina, Ali Simak, Shousha Sami, Charles Coombes R, Lam Eric W-F, Hu Yunhui, Yagüe Ernesto
Division of Cancer, Imperial College Faculty of Medicine, Hammersmith Hospital Campus, Du Cane Road, London, W12 0NN, UK.
Department of Clinical Pharmacy and Pharmacology, University of Dhaka, Dhaka, 1000, Bangladesh.
Breast Cancer Res Treat. 2018 Jan;167(2):605-606. doi: 10.1007/s10549-017-4633-6.
In the original publication, Fig. 1 depicting the blot for EP300 in CAL51 cells (Fig. 1c) was unintentionally duplicated with that from MDA-MB-231 cells (Fig. 1d). The new figure given in this erratum depicts the correct EP300 blot in Fig. 1c.
在原始出版物中，描绘CAL51细胞中EP300印迹的图1（图1c）无意中与MDA-MB-231细胞的图重复（图1d）。本勘误表中的新图展示了图1c中正确的EP300印迹。
